The Significance of Funguria in Hospitalized Patients (FACES)
This investigation is a epidemiologic case-control study of the risk factors associated with nosocomial funguria (fungi in the urine).
Urinary Tract Infections
|Study Design:||Observational Model: Case Control
Time Perspective: Prospective
|Official Title:||The Significance of Funguria in Hospitalized Patients (FACES)|
- Funguria [ Time Frame: Hospitalization day 0, 3, 7, 14, and every 7 days thereafter until hospital discharge or death ] [ Designated as safety issue: No ]
Biospecimen Retention: Samples Without DNA
Urine and blood cultures
|Study Start Date:||September 2001|
|Study Completion Date:||February 2006|
|Primary Completion Date:||February 2006 (Final data collection date for primary outcome measure)|
Patients hospitalized with a urine or blood culture positive for fungi
Patients hospitalized with a urine culture negative for fungi
A recent large multi-center national surveillance survey of almost 5000 nosocomial (hospital based) urine isolates from medical intensive care units demonstrated that fungi comprised nearly 40% of urine isolates. Little is known about distinguishing fungi that cause colonization from those causing infection.
The objective of this study is to define the epidemiology of nosocomial funguria and natural history of patients that develop funguria while hospitalized.
Patients who may have eligible for this study will be identified from microbiology laboratory specimens at the Harbor-UCLA Medical Center and Cedars-Sinai Medical Center.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00787085
|United States, California|
|Cedars-Sinai Medical Center|
|Los Angeles, California, United States, 90048|
|Harbor-UCLA Medical Center|
|Torrance, California, United States, 90509|
|Principal Investigator:||Loren G Miller, M.D., M.P.H.||Los Angeles Biomedical Research Institute|